These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 11315352)

  • 1. Treatment of systemic lupus erythematosus with bromocriptine.
    Walker SE
    Lupus; 2001; 10(3):197-202. PubMed ID: 11315352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Roles of prolactin and gonadotropin-releasing hormone in rheumatic diseases.
    Walker SE; Jacobson JD
    Rheum Dis Clin North Am; 2000 Nov; 26(4):713-36. PubMed ID: 11084941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of prolactin in stimulating disease activity in systemic lupus erythematosus.
    Walker SE; McMurray RW; Houri JM; Allen SH; Keisler D; Sharp GC; Schlechte JA
    Ann N Y Acad Sci; 1998 May; 840():762-72. PubMed ID: 9629303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of bromocriptine in an open label therapeutic trial for systemic lupus erythematosus.
    McMurray RW; Weidensaul D; Allen SH; Walker SE
    J Rheumatol; 1995 Nov; 22(11):2084-91. PubMed ID: 8596149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bromocriptine treatment of systemic lupus erythematosus.
    Walker SE
    Lupus; 2001; 10(10):762-8. PubMed ID: 11721704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mood states and disease activity in patients with systemic lupus erythematosus treated with bromocriptine.
    Walker SE; Smarr KL; Parker JC; Weidensaul DN; Nelson W; McMurray RW
    Lupus; 2000; 9(7):527-33. PubMed ID: 11035419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First reported pediatric case of systemic lupus erythematosus associated with prolactinoma.
    Reuman PD
    Arthritis Rheum; 2004 Nov; 50(11):3616-8. PubMed ID: 15529390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolactin has a pathogenic role in systemic lupus erythematosus.
    Jara LJ; Medina G; Saavedra MA; Vera-Lastra O; Torres-Aguilar H; Navarro C; Vazquez Del Mercado M; Espinoza LR
    Immunol Res; 2017 Apr; 65(2):512-523. PubMed ID: 28130617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bromocriptine in systemic lupus erythematosus: a double-blind, randomized, placebo-controlled study.
    Alvarez-Nemegyei J; Cobarrubias-Cobos A; Escalante-Triay F; Sosa-Muñoz J; Miranda JM; Jara LJ
    Lupus; 1998; 7(6):414-9. PubMed ID: 9736326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolactin modulates the disease activity of systemic lupus erythematosus accompanied by prolactinoma.
    Funauchi M; Ikoma S; Enomoto H; Sugiyama M; Ohno M; Hamada K; Kanamaru A
    Clin Exp Rheumatol; 1998; 16(4):479-82. PubMed ID: 9706433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of hormones in the treatment of lupus.
    Walker SE
    Am J Manag Care; 2001 Oct; 7(16 Suppl):S486-9. PubMed ID: 11680780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bromocriptine in rheumatic and autoimmune diseases.
    McMurray RW
    Semin Arthritis Rheum; 2001 Aug; 31(1):21-32. PubMed ID: 11503136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An SLE patient with prolactinoma and recurrent granulomatous mastitis successfully treated with hydroxychloroquine and bromocriptine.
    Zhang LN; Shi TY; Yang YJ; Zhang FC
    Lupus; 2014 Apr; 23(4):417-20. PubMed ID: 24446305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolactin: a stimulator of disease activity in systemic lupus erythematosus.
    Walker SE; Allen SH; Hoffman RW; McMurray RW
    Lupus; 1995 Feb; 4(1):3-9. PubMed ID: 7767336
    [No Abstract]   [Full Text] [Related]  

  • 15. Prolactin and systemic lupus erythematosus.
    McMurray RW
    Ann Med Interne (Paris); 1996; 147(4):253-8. PubMed ID: 8952744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bromocriptine immunomodulation of experimental SLE and primary antiphospholipid syndrome via induction of nonspecific T suppressor cells.
    Blank M; Krause I; Buskila D; Teitelbaum D; Kopolovic J; Afek A; Goldberg I; Shoenfeld Y
    Cell Immunol; 1995 Apr; 162(1):114-22. PubMed ID: 7704899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bromocriptine during pregnancy in systemic lupus erythematosus: a pilot clinical trial.
    Jara LJ; Cruz-Cruz P; Saavedra MA; Medina G; García-Flores A; Angeles U; Miranda-Limón JM
    Ann N Y Acad Sci; 2007 Sep; 1110():297-304. PubMed ID: 17911444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolactin and autoimmune diseases in humans.
    Chuang E; Molitch ME
    Acta Biomed; 2007; 78 Suppl 1():255-61. PubMed ID: 17465339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of bromocriptine on preventing postpartum flare in systemic lupus erythematosus patients from South China.
    Qian Q; Liuqin L; Hao L; Shiwen Y; Zhongping Z; Dongying C; Fan L; Hanshi X; Xiuyan Y; Yujin Y
    J Immunol Res; 2015; 2015():316965. PubMed ID: 25973434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolactin as a modulator of B cell function: implications for SLE.
    Peeva E; Venkatesh J; Michael D; Diamond B
    Biomed Pharmacother; 2004 Jun; 58(5):310-9. PubMed ID: 15194167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.